Eventide Asset Management, LLC Procept Bio Robotics Corp Transaction History
Eventide Asset Management, LLC
- $4.71 Billion
- Q1 2025
A detailed history of Eventide Asset Management, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Eventide Asset Management, LLC holds 351,962 shares of PRCT stock, worth $20.6 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
351,962
Previous 124,874
181.85%
Holding current value
$20.6 Million
Previous $10.1 Million
103.95%
% of portfolio
0.44%
Previous 0.19%
Shares
3 transactions
Others Institutions Holding PRCT
# of Institutions
300Shares Held
41.9MCall Options Held
293KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$300 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$204 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.14MShares$125 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$82.8 Million0.05% of portfolio
-
State Street Corp Boston, MA1.19MShares$69.5 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.61B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...